Key result
Prototype self-expanding nitinol stent maintains ~100% iliac patency without significant restenosis at 3 months.
Why the study?
Endovascular treatment for peripheral arterial disease is limited by frequent long-term restenosis, requiring the development of more advanced devices that preserve the integrity of the inner arterial layer.
Does a prototype self-expanding nitinol stent maintain vessel patency and preserve vascular wall integrity in an experimental pig model of peripheral artery stenting?
Does a prototype self-expanding nitinol stent maintain vessel patency and preserve vascular wall integrity in an experimental pig model of peripheral artery stenting?
A prototype self-expanding nitinol peripheral stent demonstrated 3-month patency, preserved internal elastic membrane integrity, and minimal myointimal hyperplasia in a preclinical porcine iliac artery model.
Answers are grounded in this paper and cite their sources.
New nitinol stent effects on vascular wall in PAD warrant caution; leaves open role in restenosis prevention.
Introduction. Endovascular treatment is currently the main treatment method of patients with peripheral arterial disease. The main disadvantage of this treatment method is the frequent development of restenosis in the long-term postoperative period, which necessitates the development of more advanced devices aimed at preserving the integrity of the inner layer of the artery. Objective. To study the effect of a new self-expanding nitinol stent on changes in the architecture of the vascular wall and cellular components of tissues adjacent to the implantation site by analyzing the vascular condition in laboratory pigs. Material and methods. Two Landrace pigs had stents with 5–20 % oversizing implanted in the common iliac artery. Vital signs were monitored during the follow-up; 3 days before the procedure and thereafter, dual antiplatelet therapy was used. After 3 months, angiography and ultrasound of the iliofemoral segment were performed, then the animals were euthanized. The extracted sections of the arteries with implanted stents were subjected to a thorough macroscopic and histological analysis. Results. For 3 months, the vital signs remained within the normal range. Angiography and ultrasound revealed patency of the stented area without significant restenosis. Morphological examination of the tissues demonstrated the integrity of the internal elastic membrane of the arteries. Conclusion. The implantation of the new domestic self-expanding nitinol stent caused a favorable reaction of the common iliac artery wall with minimal myointimal hyperplasia in the postoperative period. Thus, the new domestic self-expanding nitinol stent developed by us has successfully passed the stage of preclinical animal testing.
No takes yet. Share an insight, caveat, or question.
Verkhovskaya et al. (2026) studied Peripheral arterial disease experimental pig model (common iliac artery stenting) (n=2). Prototype self-expanding nitinol stent with 5-20% oversizing and dual antiplatelet therapy was evaluated on Vascular wall architecture, stent patency on angiography and ultrasound, and histological integrity of the internal elastic membrane. Prototype self-expanding nitinol stent implantation in 2 pigs maintained 100% common iliac artery patency without significant restenosis at 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: